Sabinsa Corporation was recently nominated for the 1999 Thomas Alva Edison Patent Award in the Health & medical category. This award is granted annually for recognizing the worldwide impact of science and technology. Sabinsa was selected based upon its patents for BioPerine®, a proprietary ingredient which enhances nutrient bioavailability and absorption
Other finalists included Rutgers University, Union Carbide Company, Lucent Technologies, and Bell labs. A total or eight finalists were selected. The award is bestowed by the New Jersey Research & Development Council.
Commenting on the events of the evening, Sabinsa President and CEO Dr. Muhammed Majeed noted, "Although we didn't win the award for our category, we consider ourselves winners just for being one of the finalists. We were competing against multi-billion dollar organizations and rubbing shoulders with some of the brightest research minds in the country There were no losers here tonight."
Sabinsa Corporation. which has pioneered the introduction of several Ayurvedic herbal extracts in the US market, is an application-oriented manufacturing and marketing company which manufacturers Phytonutrients, Ayurvedic herbal extracts and fine chemicals used for nutritional, pharmaceutical. cosmeceutical and food products. Sabinsa distinguishes 'itself by its extensive research support for its customers and products, and the scientific credentials of its technical staff.
